Developer docs
API playgroundTry for free, no card

Search company profiles

Cellex

Full company profile

uuid00063vf

Namestring
Cellex
Legal namestring
Cellex SrL
Websiteurl
cellex.it
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Cellex SrL, trading as Cellex Expansion Devices, is a privately-held Italian SME founded in 2018 and headquartered in Rome, with a secondary office in Wageningen, The Netherlands. The company designs, develops, and produces bioreactor systems for advanced cell culture and tissue engineering applications, serving research institutions, pharmaceutical companies, medical technology firms, and food research organizations. The firm operates with a small team — 4 named specialists against an 11–50 employee band — and is part of the Bio4Dreams biotech incubator ecosystem.

The company's product portfolio consists of two core bioreactor devices. BioAxFlow is an automated cell-seeding bioreactor that uses an external peristaltic pump and tubing to continuously circulate cell culture medium from the bottom of a vessel, lifting cells onto scaffolds and enabling uniform distribution for 3D cell culture. The device supports scaffolds of multiple geometries and is positioned around seven stated innovative characteristics. SUSPENCE is a complementary tissue engineering bioreactor. BioAxFlow has been validated in laboratory operating conditions at CNR (Italy's National Research Council) and is progressing through an industrialization phase ahead of broader commercial release. No patents, certifications, or third-party regulatory approvals are disclosed in the available data.

Cellex generates revenue primarily through one-time hardware sales of its bioreactor devices, supplemented by customization and professional services for customer-specific applications. The go-to-market motion is B2B enterprise field sales targeting scientific, medical, pharmaceutical, and food research buyers, distributed regionally through direct engagement, website contact forms, and collaborations with scientific institutes. No public pricing is disclosed, no external investors beyond Lazio Innova and Opstart are recorded, and total disclosed funding is approximately $1.1M across two rounds in 2020 and 2022.

Short descriptiontext

Cellex SrL is a Rome-based Italian SME that designs and produces bioreactor systems — notably the BioAxFlow automated cell-seeding device and SUSPENCE — for tissue engineering, serving research institutions, pharmaceutical companies, medtech firms, and food research organizations across Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRoma, Italy
HQ citystring
Roma
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioreactor systems, tissue engineering devices, cell culture equipment, 3D cell culture, bioprocess hardware
Industry2 codes
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
Product category
Bioreactor Systems for Tissue Engineering
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Bioreactor Hardware Sales
TypeOne Time License
Description

Sale of bioreactor devices (BioAxFlow, SUSPENCE) to research institutions, pharmaceutical companies, and medical technology firms for tissue engineering applications.

cellexpansiondevices.com
2Related Services
TypeProfessional Services
Description

Customization services and innovative solutions for customer needs. The company provides customized products and services tailored to specific customer requirements.

cellexpansiondevices.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1BioAxFlow
Description

Bioreactor device where cell culture medium is continuously pumped into a vessel from the bottom, lifting cells up for cell seeding on scaffolds.

cellexpansiondevices.com
+1 more record
Core offering1 text field

Cellex SrL designs, develops, and produces bioreactor devices (BioAxFlow and SUSPENCE) specifically for tissue engineering applications. The BioAxFlow bioreactor enables automated cell seeding on scaffolds of different geometries, generating uniform cell distribution for 3D cell culture. The company also provides customization services and innovative solutions tailored to specific customer research needs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Validated in laboratory conditions at CNR before industrialization phase
Product overview1 text field

Cellex SrL is an innovative Italian company based in Rome that designs, develops, and produces bioreactors specifically for tissue engineering applications. The company's product portfolio consists of two main bioreactor devices: BioAxFlow and SUSPENCE. BioAxFlow is an automated cell seeding bioreactor that enables 3D cell culture with uniform cell distribution on scaffolds using a peristaltic pump system. SUSPENCE is another tissue engineering bioreactor in their product family. Both products serve the advanced cell culture and tissue engineering markets, with BioAxFlow having been validated at Italy's National Research Council (CNR) and progressing toward industrialization.

Product and service3 records
1BioAxFlow
2SUSPENCE
3Customized Bioreactor Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1CNR (National Research Council of Italy)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CNR (National Research Council of Italy) is the largest public research institution in Italy. BioAxFlow has been validated in laboratory operating conditions at CNR before its industrialization phase, representing a key validation partnership for the technology.

cellexpansiondevices.com
Strategic tierMinorTypeOthers
Description

Cellex is part of the Bio4Dreams Ecosystem, a startup incubator/support network for biotechnology companies. Displayed as an ecosystem badge on the company website.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global bioprocess equipment leader offering a broad bioreactor portfolio for cell and gene therapy, vaccine, and tissue-engineering workflows. Overlaps with Cellex as a supplier of bioreactor systems for advanced cell culture, but at vastly larger scale and scope.

TypeBroad incumbent
Description

Established manufacturer of laboratory bioreactors and cell-culture equipment serving life-science research and biopharma. Competes with Cellex in providing bioreactor hardware for research and process-development labs, though its catalog spans many other product lines.

TypeBroad incumbent
Description

Diversified life-science tools giant with bioreactor systems, single-use bioprocess products, and cell-culture consumables. Overlaps with Cellex in serving tissue-engineering and 3D cell-culture research, but as part of a much broader catalog.

TypeBroad incumbent
Description

Major supplier of bioprocessing and cell-culture products, including bioreactor systems and cell-line development tools. Comparable to Cellex in targeting advanced cell-culture workflows from bioprocess research through manufacturing.

TypeEmerging player
Description

Swiss developer of 3D bioprinters and bio fabrication systems for tissue engineering and regenerative medicine. Comparable niche focus on hardware that automates and standardizes advanced 3D cell culture, addressing similar research customers as Cellex.

TypeEmerging player
Description

Pioneer in 3D bioprinted human tissue constructs for research and therapeutic applications. Overlaps with Cellex in tissue-engineering tooling and the broader regenerative-medicine research market, though Organovo focuses on bioprinted tissues rather than bioreactor hardware.

TypeEmerging player
Description

Startup commercializing bioprinting and tissue-engineering platforms for drug discovery and regenerative medicine. Closely comparable in scale and stage to Cellex, and addresses overlapping research and pharma customers with adjacent biofabrication tooling.

TypeEmerging player
Description

French bioprinting company developing laser-assisted 3D tissue-printing systems for pharmaceutical and cosmetic R&D. Comparable to Cellex in providing advanced tissue-engineering instrumentation to research labs, with partial overlap in target use cases.

TypeEmerging player
Description

Specialist in 3D cell-culture and tissue-engineering tools, including scaffold-based culture systems. Closely comparable niche player serving similar research customers with related 3D-culture and scaffold-handling capabilities.

TypeBroad incumbent
Description

Supplier of cell-culture reagents, GMP cytokines, and cell-therapy manufacturing tools. Tangentially comparable to Cellex as a vendor into cell-therapy and tissue-engineering manufacturing workflows, though its primary offering is consumables rather than bioreactor hardware.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellex

Bioreactor Systems for Tissue Engineeringcellex.it

Cellex SrL is a Rome-based Italian SME that designs and produces bioreactor systems — notably the BioAxFlow automated cell-seeding device and SUSPENCE — for tissue engineering, serving research institutions, pharmaceutical companies, medtech firms, and food research organizations across Europe.

What Cellex does

Cellex SrL, trading as Cellex Expansion Devices, is a privately-held Italian SME founded in 2018 and headquartered in Rome, with a secondary office in Wageningen, The Netherlands. The company designs, develops, and produces bioreactor systems for advanced cell culture and tissue engineering applications, serving research institutions, pharmaceutical companies, medical technology firms, and food research organizations. The firm operates with a small team — 4 named specialists against an 11–50 employee band — and is part of the Bio4Dreams biotech incubator ecosystem.

The company's product portfolio consists of two core bioreactor devices. BioAxFlow is an automated cell-seeding bioreactor that uses an external peristaltic pump and tubing to continuously circulate cell culture medium from the bottom of a vessel, lifting cells onto scaffolds and enabling uniform distribution for 3D cell culture. The device supports scaffolds of multiple geometries and is positioned around seven stated innovative characteristics. SUSPENCE is a complementary tissue engineering bioreactor. BioAxFlow has been validated in laboratory operating conditions at CNR (Italy's National Research Council) and is progressing through an industrialization phase ahead of broader commercial release. No patents, certifications, or third-party regulatory approvals are disclosed in the available data.

Cellex generates revenue primarily through one-time hardware sales of its bioreactor devices, supplemented by customization and professional services for customer-specific applications. The go-to-market motion is B2B enterprise field sales targeting scientific, medical, pharmaceutical, and food research buyers, distributed regionally through direct engagement, website contact forms, and collaborations with scientific institutes. No public pricing is disclosed, no external investors beyond Lazio Innova and Opstart are recorded, and total disclosed funding is approximately $1.1M across two rounds in 2020 and 2022.

Cellex firmographics

Firmographics
Name
Cellex
Legal name
Cellex SrL
Website
https://cellex.it
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Cellex SrL is a Rome-based Italian SME that designs and produces bioreactor systems — notably the BioAxFlow automated cell-seeding device and SUSPENCE — for tissue engineering, serving research institutions, pharmaceutical companies, medtech firms, and food research organizations across Europe.
Ownership category
akta.pro rank

Cellex industry classification

Industry
Product category
Bioreactor Systems for Tissue Engineering
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAAAGAC
3D Bioprinting & Biofabrication
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

  • Bioreactor systems
  • Tissue engineering devices
  • Cell culture equipment
  • 3D cell culture
  • Bioprocess hardware

Where Cellex is headquartered

Location

Headquarters

HQ city
Roma
HQ country
Italy
HQ region
Europe

Offices4 records

Markets served

Cellex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Bioreactor Hardware Sales: Sale of bioreactor devices (BioAxFlow, SUSPENCE) to research institutions, pharmaceutical companies, and medical technology firms for tissue engineering applications.
  2. Related Services: Customization services and innovative solutions for customer needs. The company provides customized products and services tailored to specific customer requirements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Cellex product offering

Product offering

Core offering

Cellex SrL designs, develops, and produces bioreactor devices (BioAxFlow and SUSPENCE) specifically for tissue engineering applications. The BioAxFlow bioreactor enables automated cell seeding on scaffolds of different geometries, generating uniform cell distribution for 3D cell culture. The company also provides customization services and innovative solutions tailored to specific customer research needs.

Product overview

Cellex SrL is an innovative Italian company based in Rome that designs, develops, and produces bioreactors specifically for tissue engineering applications. The company's product portfolio consists of two main bioreactor devices: BioAxFlow and SUSPENCE. BioAxFlow is an automated cell seeding bioreactor that enables 3D cell culture with uniform cell distribution on scaffolds using a peristaltic pump system. SUSPENCE is another tissue engineering bioreactor in their product family. Both products serve the advanced cell culture and tissue engineering markets, with BioAxFlow having been validated at Italy's National Research Council (CNR) and progressing toward industrialization.

Differentiator

Problem solved

Functional benefit

Brands

  • BioAxFlow: Bioreactor device where cell culture medium is continuously pumped into a vessel from the bottom, lifting cells up for cell seeding on scaffolds.
  • SUSPENCE

Products and services

  • BioAxFlow
  • SUSPENCE
  • Customized Bioreactor Services

Quantifiable outcome

  • Validated in laboratory conditions at CNR before industrialization phase

Companies that use Cellex

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Cellex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cellex partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • CNR (National Research Council of Italy)coreStrategic or Co-development PartnerCNR (National Research Council of Italy) is the largest public research institution in Italy. BioAxFlow has been validated in laboratory operating conditions at CNR before its industrialization phase, representing a key validation partnership for the technology.
  • Bio4Dreams EcosystemminorOthersCellex is part of the Bio4Dreams Ecosystem, a startup incubator/support network for biotechnology companies. Displayed as an ecosystem badge on the company website.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Cellex competitors and assessment

Company assessment

Broad incumbents

  • Sartorius: Global bioprocess equipment leader offering a broad bioreactor portfolio for cell and gene therapy, vaccine, and tissue-engineering workflows. Overlaps with Cellex as a supplier of bioreactor systems for advanced cell culture, but at vastly larger scale and scope.
  • Eppendorf: Established manufacturer of laboratory bioreactors and cell-culture equipment serving life-science research and biopharma. Competes with Cellex in providing bioreactor hardware for research and process-development labs, though its catalog spans many other product lines.
  • Thermo Fisher Scientific: Diversified life-science tools giant with bioreactor systems, single-use bioprocess products, and cell-culture consumables. Overlaps with Cellex in serving tissue-engineering and 3D cell-culture research, but as part of a much broader catalog.
  • Merck KGaA (Life Science): Major supplier of bioprocessing and cell-culture products, including bioreactor systems and cell-line development tools. Comparable to Cellex in targeting advanced cell-culture workflows from bioprocess research through manufacturing.
  • CellGenix: Supplier of cell-culture reagents, GMP cytokines, and cell-therapy manufacturing tools. Tangentially comparable to Cellex as a vendor into cell-therapy and tissue-engineering manufacturing workflows, though its primary offering is consumables rather than bioreactor hardware.

Emerging players

  • RegenHU: Swiss developer of 3D bioprinters and bio fabrication systems for tissue engineering and regenerative medicine. Comparable niche focus on hardware that automates and standardizes advanced 3D cell culture, addressing similar research customers as Cellex.
  • Organovo: Pioneer in 3D bioprinted human tissue constructs for research and therapeutic applications. Overlaps with Cellex in tissue-engineering tooling and the broader regenerative-medicine research market, though Organovo focuses on bioprinted tissues rather than bioreactor hardware.
  • TissueLabs: Startup commercializing bioprinting and tissue-engineering platforms for drug discovery and regenerative medicine. Closely comparable in scale and stage to Cellex, and addresses overlapping research and pharma customers with adjacent biofabrication tooling.
  • Poietis: French bioprinting company developing laser-assisted 3D tissue-printing systems for pharmaceutical and cosmetic R&D. Comparable to Cellex in providing advanced tissue-engineering instrumentation to research labs, with partial overlap in target use cases.
  • 3D Biotek: Specialist in 3D cell-culture and tissue-engineering tools, including scaffold-based culture systems. Closely comparable niche player serving similar research customers with related 3D-culture and scaffold-handling capabilities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Cellex social profiles

Digital presence

Cellex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellex leadership team

Management profile

Number of profiles

Profiles4 records

Cellex funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellex

What does Cellex do?

Cellex SrL designs, develops, and produces bioreactor devices (BioAxFlow and SUSPENCE) specifically for tissue engineering applications. The BioAxFlow bioreactor enables automated cell seeding on scaffolds of different geometries, generating uniform cell distribution for 3D cell culture. The company also provides customization services and innovative solutions tailored to specific customer research needs.

Is Cellex a public or private company?

Cellex is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cellex founded?

Cellex was founded in 2018. It employs 1 to 10 people.

Where is Cellex based?

Cellex is headquartered in Roma, Italy, in the Europe region.

How does Cellex make money?

Two revenue lines are on record. Bioreactor Hardware Sales are the primary driver. The others are related Services.

Who are Cellex's main competitors?

Broad incumbents on record are Sartorius, Eppendorf, Thermo Fisher Scientific, Merck KGaA (Life Science) and CellGenix. Emerging players are RegenHU, Organovo, TissueLabs, Poietis and 3D Biotek.

Does Cellex have an API?

No public API is recorded for Cellex.

What industry is Cellex in?

Cellex's product category is Bioreactor Systems for Tissue Engineering. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAAAGAC, 3D Bioprinting & Biofabrication. Its NAICS code is 541714 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales